Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1–PI3K–AKT signaling pathway and GLUT4 expression

摘要

Panax notoginseng saponins (PNS) are a commonly used traditional medicine to treat diabetes in China. Recent studies have confirmed their anti‐diabetic effects, but the underlying mechanisms have remained unclear. The present study was designed to explore whether PNS decrease hyperglycemia by improving insulin sensitivity in skeletal muscle and to elucidate the molecular mechanisms. The anti‐diabetic effects of PNS were analyzed in a skeletal myoblast cell line, C2C12, and in high fat diet‐induced diabetic KKAy mice. C2C12 cells were treated with PNS (50, 100, and 200 μg·L⁻¹) and examined for glucose uptake, cell viability and expression of components of the phosphoinositide 3‐kinase (PI3K)–protein kinase B (AKT) signaling pathway. KKAy mice were intraperitoneally injected with PNS (200 mg·kg⁻¹) for 6 weeks. Body weight, blood glucose, serum insulin, serum lipid, glucose and insulin tolerance were measured to evaluate the anti‐diabetic effects of PNS. Pathological changes, apoptosis and the PI3K–AKT signaling pathway were analyzed in KKAy skeletal muscle. PNS significantly increased insulin‐induced glucose uptake, but did not affect the cell viability of C2C12 cells. In addition, PNS reduced blood glucose and serum insulin levels and improved glucose tolerance and insulin tolerance of KKAy mice. Pathological changes and apoptosis of skeletal muscle were relieved by style="fixed-case">PNS treatment. Moreover, style="fixed-case">PNS treatment enhanced expression of style="fixed-case">mRNA encoding style="fixed-case">IRS1 and style="fixed-case">GLUT4, as well as the protein expression of phosphorylated (p) ‐insulin receptor substrate 1 ( style="fixed-case">IRS1), p‐ style="fixed-case">PI3K, p‐ style="fixed-case">AKT and glucose transporter type 4 ( style="fixed-case">GLUT4) in C2C12 and style="fixed-case">KKAy mouse muscle. Collectively, these data indicate that style="fixed-case">PNS reduces hyperglycemia and insulin resistance through up‐regulating style="fixed-case">GLUT4 expression and the style="fixed-case">IRS1– style="fixed-case">PI3K– style="fixed-case">AKT signaling pathway. Furthermore, style="fixed-case">PNS alleviated diabetes skeletal muscle pathological damage. Thus, our data suggest that style="fixed-case">PNS may be promising anti‐diabetic compounds.